Alex Goldberg

NASDAQ Active Stock Watch List: Paychex, Inc. (NASDAQ:PAYX) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/10/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Paychex, Inc. (NASDAQ:PAYX) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).

Paychex, Inc. (NASDAQ:PAYX) a company that together with its subsidiaries, provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany is currently down (-0.51%) on 626,840 shares traded. Paychex, Inc. (NASDAQ:PAYX) is currently down (-11.69%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Paychex, Inc. (NASDAQ:PAYX)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases is currently up (+2.50%) on 2,003,010 shares traded after Arena Pharmaceuticals Reported Coverage for BELVIQ CIV Now Greater Than 50% of Insured Commercial Lives. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is currently up (+53.83%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com